Northwire Canada EditionFriday, October 16, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4207.30 +0.9% SILVER 57.77 +1.1% COPPER 6.61 +0.8% OIL 95.90 −2.1% PALLADIUM 1129.75 +0.1% OMI 0.250 +0.0% BUFF 0.810 +3.9% FEO 0.650 +0.0% LIB 0.750 +4.2% NPR 0.630 +1.6% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.540 +3.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.55 −2.8% CASA 0.060 +0.0% DRY 0.225 +4.7% SOMA 0.550 −1.8% PWRO 0.025 +0.0% GOLD 4207.30 +0.9% SILVER 57.77 +1.1% COPPER 6.61 +0.8% OIL 95.90 −2.1% PALLADIUM 1129.75 +0.1% OMI 0.250 +0.0% BUFF 0.810 +3.9% FEO 0.650 +0.0% LIB 0.750 +4.2% NPR 0.630 +1.6% QZM 0.380 +0.0% BVA 0.750 −1.3% ONAU 0.540 +3.9% FMR 0.225 +0.0% GSVR 0.355 +4.4% PHNM 0.345 +1.5% SLG 5.55 −2.8% CASA 0.060 +0.0% DRY 0.225 +4.7% SOMA 0.550 −1.8% PWRO 0.025 +0.0%
M&A / Property

Ventripoint Diagnostics Ltd. Signs Commercial Agreement with LG Consulting Solutions to Support VMS+ Deployment in Northern California

By The Northwire Desk — AI Analysis Mar 03, 2026 · 08:00 VPT · 0.11 VentriPoint Diagnostics Ltd.
VPT · Price

Executive Summary

  • Ventripoint Diagnostics Ltd. signed a Memorandum of Understanding and consulting agreement with LG Consulting Solutions to commercialize the VMS+™ AI‑enhanced echocardiography system in Northern California.
  • LG Consulting will purchase a VMS+™ system for demonstration, provide economic analysis, clinical implementation support, and develop health‑system business cases.
  • The collaboration includes potential revenue sharing on 3D echocardiography processing services and aims to generate measurable clinical and economic value for hospitals and cardiac programs.

Key Details

  • Agreement Scope: MoU and consulting agreement covering economic analysis, clinical implementation support, and health‑system business case development for VMS+™ in Sacramento and San Francisco regions.
  • System Purchase: LG Consulting Solutions will acquire one VMS+™ system to serve as a demonstration and training platform for targeted healthcare institutions.
  • Consulting Services: Outcomes evaluation, implementation planning, and ongoing operational support to help hospitals assess clinical and economic impact of AI‑enhanced echocardiography.
  • Revenue Sharing: Potential sharing of revenues derived from 3D echocardiography processing services linked to accounts supported by the consulting engagement.
  • Strategic Rationale: Northern California is identified as a high‑value market due to its concentration of leading cardiac centers and focus on improving cardiovascular outcomes and operational efficiency.
  • Leadership Quote: Hugh MacNaught, President & CEO, emphasized that the partnership will provide “economic and operational clarity” to accelerate adoption of VMS+™ technology.

Notable Quotes

“Economic and operational clarity are critical to accelerating the adoption of new medical technologies,” – Hugh MacNaught, President & CEO, Ventripoint Diagnostics Ltd.

“Healthcare systems increasingly require clear clinical and economic evidence before adopting new technologies… we will work directly with cardiac programs to develop practical implementation strategies,” – Lori Gallian, Principal, LG Consulting Solutions.

Read the original news release →

More from VentriPoint Diagnostics Ltd.

Jun 26, 2026 · 08:10

AI cardiac imaging startup scaling niche partnerships while navigating a critical $55k cash balance and negative working capital.

M&A / Property Jun 16, 2026 · 09:11

AI cardiac imaging startup scales commercial partnerships but remains cash-constrained and pre-revenue at scale.

Other Apr 28, 2026 · 08:00

Ventripoint Advances China Entry Amidst Persistent Dilution Concerns

Regulatory Apr 20, 2026 · 08:50

Ventripoint Wins Gold Edison Award But Cash Burn and Dilution Risks Persist

Other Apr 16, 2026 · 11:00

TSXV Venture Exchange Listed Cardiac Imaging Platform

M&A / Property Apr 01, 2026 · 22:50

Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

M&A / Property